Hepatic Mac2‐BP expression depends on liver fibrosis and inflammation due to fat accumulation in patients with metabolic dysfunction‐associated steatotic liver disease

Documenti analoghi

• Digital Polymerase Chain Reaction‐Based Fecal Streptococcus Quantification for Liver Fibrosis Assessment in Chronic Liver Disease
  di: Nomura Nao, et al.
  Pubblicazione: (2025)
• Thy‐1 restricts steatosis and liver fibrosis in steatotic liver disease
  di: Valentin Blank, et al.
  Pubblicazione: (2024)
• Association of liver fibrosis progression with non–liver‐related mortality in metabolic dysfunction‐associated steatotic liver disease
  di: Toshifumi Tada, et al.
  Pubblicazione: (2025)
• Randomized Controlled Trial of Endoscopic Ultrasound‐Guided Liver Biopsy Versus Percutaneous Liver Biopsy for Obtaining Histologically Adequate Specimens
  di: Kosuke Okuwaki, et al.
  Pubblicazione: (2026)
• Molecular pathogenesis of metabolic dysfunction‐associated steatotic liver disease, steatohepatitis, hepatic fibrosis and liver cirrhosis
  di: Takashi Saito, et al.
  Pubblicazione: (2024)